FTC's Bedoya Says Antitrust Cares Too Much About Efficiency
Newswire
FTC Caught in Balancing Act With Pharmacy Benefit Manager Probe
FTC Goes After PBMs, Warns Of Legal Action
Lawmakers ask GAO to probe pharmacy benefit managers over their role in drug pricing
FTC Probe Into Rx Middlemen May Spark Industry Shakeup
Federal Trade Commission And Congress Want To Rein In PBMs
Industry middlemen driving up prices of generic drug prescriptions as much as 20 percent: research
AHA presses for False Claims Act probes to target payers over Medicare Advantage denials
Biden plan to slash pharmacy fees, cut seniors' out-of-pocket costs delayed until 2024
Louisiana sues health care company over practices under investigation in Ohio
Prospect of lower fees for prescription drugs could be dashed by new maneuver from PBMs
Bipartisan pressure may prompt Federal Trade Commission to investigate drug middlemen
Yost opens investigation into PBM maneuver
More than $300 Billion in Health Care Spending Goes to Middlemen. We Need Accountability.
Pharmacy Agent Study Would Show Role in Drug Price ‘Dysfunction’
To Be, Or Not To Be... A Fiduciary
We Need Your Support Today!